BioCentury
ARTICLE | Company News

amp biosimilars deal

July 20, 2015 7:00 AM UTC

amp granted an undisclosed Chinese pharmaceutical company exclusive, Chinese rights to ABY-018. The humanized mAb is a biosimilar of an undisclosed cancer product. The undisclosed company will fund d...